DETECT: Recognizing and Treating Alzheimer’s Disease
Moving Towards Early Diagnosis and Disease Management

Philadelphia

Provided by Med Learning Group.
Co-provided by UMA/CCM

Supported by an Educational Grant from Lilly USA, LLC.

Scroll to the Bottom of this Information to Begin this Course

Release date: December 9, 2016

Valid through: December 9, 2017

Specialty: Alzheimer’s Disease

Media: Internet

Estimated Time to Complete Activity: 60 minutes

Target Audience

This activity is designed to meet the educational needs of neurologists, psychiatrists, internal medicine and family medicine practitioners, and other HCPs (NPs, PAs, clinical nurse specialists, etc.), who would like to receive additional training in the assessment and care of patients with cognitive impairment.

Program Overview

This enduring activity is focused on the early diagnosis and management of Alzheimer’s disease.

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Describe the pathophysiology of Alzheimer’s disease (AD) and the roles of clinical assessment and biomarkers in the workup of cognitive impairment
  • Recognize the importance of early diagnosis, and identify challenges in obtaining an early and accurate diagnosis of AD versus other causes of cognitive impairment
  • Utilize diagnostic algorithms and tools to assist in the detection of cognitive impairment, and discuss their use in the clinic
  • Review current treatment approaches and investigational therapies for the early stages of AD, their mechanisms of action and clinical updates
  • Discuss the individualization of AD management based on stage, comorbidities, the presence and type of additional symptoms, and other patient-related factors
  • Develop strategies for improving communication with patients with early AD and their caregivers and for referring their families to local and national support structures

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit
  • Nurses — 1.0 ANCC Credit Hour
  • Pharmacists — 1.0 Contact Hour

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Marc E. Agronin, MD

Marc E. Agronin, MD

Medical Director for Mental Health and Clinical Research
Miami Jewish Health Systems (MJHS)
Affiliate Associate Professor of Psychiatry and Neurology
University of Miami Miller School of Medicine
Miami, Florida

Bradford C. Dickerson, MD

Bradford C. Dickerson, MD

Associate Professor of Neurology, Harvard Medical School
Director, Frontotemporal Disorders Unit
Behavioral Neurologist, Alzheimer’s disease Research Center,
Massachusetts General Hospital
Charlestown, Massachusetts

Barry W. Rovner, MD

Barry W. Rovner, MD

Professor, Departments of Psychiatry and Neurology
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania

Physician Continuing Medical Education

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Purpose: This program would be beneficial for nurses involved in the care of patients with AD.

Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

Pharmacist Continuing Education

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 1 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance. UAN# 0453-9999-16-095-H01-P(K)

AAPA Accreditation

This program has been reviewed and is approved for a maximum of 1.00 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.
This program was planned in accordance with AAPA's CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.

AOA Credit

The American Osteopathic Association (AOA) Council on Continuing Medical Education has APPROVED this activity for 1 AOA Category 2-A credits.



Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Dr. Agronin has consulted with Eli Lilly and served on Speaker’s Bureau for Allergan. He has received research grants from Eisai, Inc., Eli Lilly, Biogen Pharmaceuticals, Neuronix, Neurotrope BioScience, Axovant Sciences, Hoffman La-Roche, Genentech, Accera, Inc., Astra-Zeneca, Chase Pharmaceuticals, Merck, Lundbeck, Neurim Pharmaceuticals, T3D Therapeutics, Otsuka Pharmaceutical, and Transtech Pharma.

Dr. Dickerson has consulted for Forum Pharmaceuticals, served on the DSMB for Merck, and serves as an editor for Oxford Pharma.

Dr. Rovner has nothing to disclose.

CME Content Review
The content of this activity was independently peer reviewed.

M. Susan Burke, MD has consulted with Iroko and Merck, Inc.  

CNE Content Review
Lynnsey Grzybowski, RN has no relevant financial relationships to disclose.
Anne Knieriem RN, MSN, has no relevant financial relationships to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Flavia Piazza, VP, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
Serena Konduru, MPA, Program Manager for Med Learning Group, has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Agronin, Dr. Dickerson, and Dr. Rovner may mention the use of medications for both FDA-approved and non-approved indications.

Instructions for Participation and Credit

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate via email.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Content - Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Download Additional Toolkit